4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol

C82H117F3N18O8 — CID 159694866

IUPAC4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol
SMILESC=C(C1CCC(c2cc(C3CCC(O)CC3)n3nc(N[C@@H](C)CC(F)(F)F)ncc23)CC1)N1CCOCC1.CC(CC1COC1)Nc1ncc2c(-c3cnn(C4CCC4)c3)cc(C3CCC(O)CC3)n2n1.COC[C@H](C)Nc1ncc2c(-c3cnn(C(C)(C)C(=O)N4CCC(C)(O)CC4)c3)cc(C3CCC(O)CC3)n2n1
InChIInChI=1S/C29H43N7O4.C28H40F3N5O2.C25H34N6O2/c1-19(18-40-5)32-27-30-16-25-23(14-24(36(25)33-27)20-6-8-22(37)9-7-20)21-15-31-35(17-21)28(2,3)26(38)34-12-10-29(4,39)11-13-34;1-18(16-28(29,30)31)33-27-32-17-26-24(15-25(36(26)34-27)22-7-9-23(37)10-8-22)21-5-3-20(4-6-21)19(2)35-11-13-38-14-12-35;1-16(9-17-14-33-15-17)28-25-26-12-24-22(19-11-27-30(13-19)20-3-2-4-20)10-23(31(24)29-25)18-5-7-21(32)8-6-18/h14-17,19-20,22,37,39H,6-13,18H2,1-5H3,(H,32,33);15,17-18,20-23,37H,2-14,16H2,1H3,(H,33,34);10-13,16-18,20-21,32H,2-9,14-15H2,1H3,(H,28,29)/t19-,20?,22?;18-,20?,21?,22?,23?;/m00./s1
InChIKeyMWWMHHOYLAMSED-NVCUDTBBSA-N
MW1539.95 g/mol
LogP12.96
Rot. Bonds22

About 4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol

4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol (PubChem CID 159694866) has the molecular formula C82H117F3N18O8 and a molecular weight of 1539.95 g/mol. Its IUPAC name is 4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol.

Molecular Properties

Compound Name4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol
PubChem CID159694866
Molecular FormulaC82H117F3N18O8
Molecular Weight1539.95 g/mol
Exact Mass1538.93
IUPAC Name4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol
SMILESC=C(C1CCC(c2cc(C3CCC(O)CC3)n3nc(N[C@@H](C)CC(F)(F)F)ncc23)CC1)N1CCOCC1.CC(CC1COC1)Nc1ncc2c(-c3cnn(C4CCC4)c3)cc(C3CCC(O)CC3)n2n1.COC[C@H](C)Nc1ncc2c(-c3cnn(C(C)(C)C(=O)N4CCC(C)(O)CC4)c3)cc(C3CCC(O)CC3)n2n1
InChIInChI=1S/C29H43N7O4.C28H40F3N5O2.C25H34N6O2/c1-19(18-40-5)32-27-30-16-25-23(14-24(36(25)33-27)20-6-8-22(37)9-7-20)21-15-31-35(17-21)28(2,3)26(38)34-12-10-29(4,39)11-13-34;1-18(16-28(29,30)31)33-27-32-17-26-24(15-25(36(26)34-27)22-7-9-23(37)10-8-22)21-5-3-20(4-6-21)19(2)35-11-13-38-14-12-35;1-16(9-17-14-33-15-17)28-25-26-12-24-22(19-11-27-30(13-19)20-3-2-4-20)10-23(31(24)29-25)18-5-7-21(32)8-6-18/h14-17,19-20,22,37,39H,6-13,18H2,1-5H3,(H,32,33);15,17-18,20-23,37H,2-14,16H2,1H3,(H,33,34);10-13,16-18,20-21,32H,2-9,14-15H2,1H3,(H,28,29)/t19-,20?,22?;18-,20?,21?,22?,23?;/m00./s1
InChIKeyMWWMHHOYLAMSED-NVCUDTBBSA-N
XLogP12.96
TPSA294.46 Ų
H-Bond Donors7
H-Bond Acceptors25
Rotatable Bonds22
Heavy Atoms111
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001539.95
LogP ≤ 512.96
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1025

Analyze 4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol?
The IUPAC name of 4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol (CID 159694866) is 4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol.
What is the SMILES notation for 4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol?
The canonical SMILES for 4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol is C=C(C1CCC(c2cc(C3CCC(O)CC3)n3nc(N[C@@H](C)CC(F)(F)F)ncc23)CC1)N1CCOCC1.CC(CC1COC1)Nc1ncc2c(-c3cnn(C4CCC4)c3)cc(C3CCC(O)CC3)n2n1.COC[C@H](C)Nc1ncc2c(-c3cnn(C(C)(C)C(=O)N4CCC(C)(O)CC4)c3)cc(C3CCC(O)CC3)n2n1.
What is the InChIKey of 4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol?
The InChIKey is MWWMHHOYLAMSED-NVCUDTBBSA-N. The full InChI is InChI=1S/C29H43N7O4.C28H40F3N5O2.C25H34N6O2/c1-19(18-40-5)32-27-30-16-25-23(14-24(36(25)33-27)20-6-8-22(37)9-7-20)21-15-31-35(17-21)28(2,3)26(38)34-12-10-29(4,39)11-13-34;1-18(16-28(29,30)31)33-27-32-17-26-24(15-25(36(26)34-27)22-7-9-23(37)10-8-22)21-5-3-20(4-6-21)19(2)35-11-13-38-14-12-35;1-16(9-17-14-33-15-17)28-25-26-12-24-22(19-11-27-30(13-19)20-3-2-4-20)10-23(31(24)29-25)18-5-7-21(32)8-6-18/h14-17,19-20,22,37,39H,6-13,18H2,1-5H3,(H,32,33);15,17-18,20-23,37H,2-14,16H2,1H3,(H,33,34);10-13,16-18,20-21,32H,2-9,14-15H2,1H3,(H,28,29)/t19-,20?,22?;18-,20?,21?,22?,23?;/m00./s1.
What are the key properties of 4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol?
4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol has a molecular weight of 1539.95 g/mol, XLogP of 12.96, 22 rotatable bonds, 7 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-(1-cyclobutylpyrazol-4-yl)-2-[1-(oxetan-3-yl)propan-2-ylamino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;2-[4-[7-(4-hydroxycyclohexyl)-2-[[(2S)-1-methoxypropan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]pyrazol-1-yl]-1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;4-[5-[4-(1-morpholin-4-ylethenyl)cyclohexyl]-2-[[(2S)-4,4,4-trifluorobutan-2-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol is sourced from PubChem (CID 159694866), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).